Molecular Diagnostics Market Extensive Industry Analysis, Growth Rate, Segmentation, Investment Opportunities and Top Manufacturers 2035

This report presents a detailed, data-driven analysis of the global Molecular Diagnostics Market size, offering insights into historical performance, current dynamics, and projections from 2025 to 2035. With a strong emphasis on factual assessment, the report refrains from speculative assumptions and aims to support business decisions through accurate forecasting and strategic intelligence.

I recently came across a report by Roots Analysis that really put things into perspective. According to them, The global molecular diagnostics market, valued at USD 17 billion in 2025, is projected to reach USD 18 billion in 2026 and USD 31 billion by 2035, with a 6.4% CAGR during the forecast period 2026 to 2035.

Reference - https://www.rootsanalysis.com/reports/molecular-diagnostics-market.html

Market Segmentation

• Historical Trend: Since 2018
• Forecast Period: Till 2035
• Market Size 2026: $ 18 Billion
• Market Size 2035: $ 31 Billion
• CAGR (Till 2035): 6.4%
• Test Type • Laboratory Testing • Point-of-Care Testing
• Type of Offering • Reagents • Instruments • Services
• Type of Sample • Blood, Serum and Plasma • Urine • Others
• Type of Technology • Polymerase Chain Reaction (PCR) • In situ Hybridization • Isothermal Nucleic Acid Amplification Technology • Next Generation Sequencing • Microarrays • Mass Spectrometry • Others
• Therapeutic Area • Cardiovascular Diseases • Genetic Diseases • Infectious Diseases • Neurological Diseases • Oncological Disorders • Others
• End User • Hospitals • Laboratories • Others
• Geographical Regions • North America ◦ US ◦ Canada • Europe ◦ Austria ◦ Belgium ◦ Germany ◦ France ◦ UK ◦ Italy ◦ Spain ◦ Netherlands ◦ Poland ◦ Switzerland ◦ Rest of the Europe • Asia ◦ China ◦ Japan ◦ India ◦ Indonesia ◦ South Korea ◦ Singapore ◦ Thailand ◦ Rest of Asia • Latin America ◦ Brazil ◦ Argentina ◦ Mexico ◦ Rest of Latin America • Middle East and North Africa ◦ Egypt ◦ Israel ◦ Saudi Arabia ◦ Rest of Middle East and North Africa • Rest of the World ◦ Australia ◦ New Zealand
• Excel Data Packs (Complimentary) • Market Landscape • Company Competitiveness Analysis • Market Forecast and Opportunity Analysis
• Key Players • Abbott Laboratories • Agilent Technologies • Becton Dickinson • BGI Genomics • bioMerieux • Bio-Rad • Danaher • DiaSorin • Grifols • Hologic • Illumina • Qiagen • QuidelOrtho • Revvity • Roche • Sansure • Seegene • Siemens Healthineers • Sysmex • Thermo Fisher Scientific
• PowerPoint Presentation (Complimentary): Available
• Customization Scope: 15% Free Customization

Key Geographies

North America
Europe
Asia-Pacific
Middle East and North Africa
Latin America
Each segment is analyzed by volume, value, and growth patterns, offering a comparative understanding of usage trends and market opportunities.

Market Share Insights
▪ Market Share by Type of Sample: Blood, Serum and Plasma Segment to Hold the Highest Market Share
▪ Market Share by Type of Offering: Reagents Segment to Dominate the Overall Market
▪ Market Share by Therapeutic Area: Infectious Diseases Segment to Dominate the Overall Market

Analytical Insights Covered

▪ Market Landscape
▪ Company Competitiveness Analysis
▪ Market Forecast and Opportunity Analysis

Key Players Include:

Andermatt
Bayer
BioSafe Systems
Certis Biologicals
Corteva Agriscience
Novozymes
Nutri-Tech Solutions
ProFarm
Syngenta
Valent Biosciences
These companies are assessed based on their contributions to market share, innovation, and responsiveness to global and regional demand shifts.

Regional Insights

Each region is evaluated based on:

Historical market trends and sales data
Regulatory frameworks
Product availability and distribution strength
Emerging opportunities and constraints
Comparative regional analysis enables better targeting of expansion strategies and investment planning.

Supply Chain & Operational Overview

This section covers:

Pricing structures
Distribution channels
Manufacturing capabilities
Cost breakdowns and logistics trends
Understanding operational flows adds value to strategic sourcing and capacity expansion discussions.

Research Methodology

This report is developed using a combination of:

Primary research: Expert interviews, corporate disclosures
Secondary research: Company websites, public filings, databases, and published literature
All data points were reviewed for consistency, ensuring neutrality, reliability, and practical relevance for stakeholders and strategic planners.

Conclusion and Customization

This Molecular Diagnostics Market report serves as a foundational reference for:

Market entry and expansion strategies
Product development roadmaps
Investment decision-making
For custom data slices or tailored analysis by geography, product, or competitor, please contact [e-mail].